SCHEMBL7227482

SCHEMBL7227482

C(=CCN1CCCCC1)CN1CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 4/20 0.43
LTA4H P09960 1/20 0.41
CHRNB2 P17787 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA4 P43681 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
LMNA P02545 1/20 0.38
CARM1 Q86X55 1/20 0.38
PRMT6 Q96LA8 1/20 0.38
PRMT8 Q9NR22 1/20 0.38
CHRM5 P08912 1/20 0.38
ADRA2C P18825 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
MAPT P10636 2/20 0.36
GAA P10253 1/20 0.35
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10748748 1.00 HRH3 (0.43) HRH3LTA4HCHRNB2CHRNB4CHRNA3
SCHEMBL23872301 1.00 HRH3 (0.43) HRH3LTA4HCHRNB2CHRNB4CHRNA3
SCHEMBL23872300 0.97 LTA4H (0.42) HRH3LTA4HCHRNB2CHRNB4CHRNA3
SCHEMBL15901908 0.87 LTA4H (0.35) HRH3LTA4HCHRNB2CHRNB4CHRNA3
SCHEMBL9330121 0.87 CHRNB2 (0.38) HRH3LTA4HCHRNB2CHRNB4CHRNA3
SCHEMBL28552521 0.87 TDP1 (0.40) HRH3LTA4HCHRNB2CHRNB4CHRNA3
SCHEMBL18281174 0.87 ALDH1A1 (0.40) HRH3LTA4HCHRNB2CHRNB4CHRNA3
SCHEMBL6800629 0.87 TDP1 (0.40) HRH3LTA4HCHRNB2CHRNB4CHRNA3
SCHEMBL15901535 0.87 LTA4H (0.35) HRH3LTA4HCHRNB2CHRNB4CHRNA3
SCHEMBL15901454 0.87 LTA4H (0.35) HRH3LTA4HCHRNB2CHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6576791-B1 Local anesthetic compounds and uses THERAVANCE, INC. 2003-06-10 US disclosed
US-6495681-B1 PRODUCING LOCAL ANESTHESIA OF LONG-DURATION. THE COMPOUNDS OF THIS INVENTION ARE MULTIBINDING COMPOUNDS THAT COMPRISE FROM 2 TO 10 LIGANDS COVALENTLY ATTACHED TO A LINKER OR LINKERS, EACH LIGAND BEING CAPABLE OF BINDING TO A LIGAND BINDING SITE THERAVANCE INC. 2002-12-17 US disclosed
US-6462034-B1 MULTIBINDING COMPOUNDS CONTAINING A SYMETRICAL DIAMINOTETRA-ETHERDODECANE RING WITH TWO SECONDARY AMIDE AND ADDITIONAL SUBSTITUENTS; VOLTAGE GATED SODIUM CHANNEL MODULATORS; LONG DURATION THERAVANCE, INC. 2002-10-08 US disclosed
US-6337423-B1 BIND TO VOLTAGE-GATED SODIUM ION CHANNELS TO MODULATE ACTIVITY ADVANCED MEDICINE, INC. 2002-01-08 US disclosed
EP-1066245-A4 NOVEL LOCAL ANESTHETIC COMPOUNDS AND USES ADVANCED MEDICINE INC (US) 2001-01-24 EP disclosed
EP-1066245-A1 NOVEL LOCAL ANESTHETIC COMPOUNDS AND USES Advanced Medicine, Inc. (US) 2001-01-10 EP disclosed
WO-1999051565-A9 NOVEL LOCAL ANESTHETIC COMPOUNDS AND USES ADVANCED MEDICINE INC (US) 1999-12-02 WO disclosed
WO-1999051565-A1 NOVEL LOCAL ANESTHETIC COMPOUNDS AND USES ADVANCED MEDICINE, INC. (US) 1999-10-14 WO disclosed